BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25504022)

  • 21. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
    Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.
    Chung HH; Cheon GJ; Kim JW; Park NH; Song YS
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):47-55. PubMed ID: 28828510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
    Inubashiri E; Hata K; Kanenishi K; Shiota A; Ohno M; Yamamoto Y; Nishiyama Y; Ohkawa M; Hata T
    J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
    Antonsen SL; Loft A; Fisker R; Nielsen AL; Andersen ES; Høgdall E; Tabor A; Jochumsen K; Fagö-Olsen CL; Asmussen J; Berthelsen AK; Christensen IJ; Høgdall C
    Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
    Stecco A; Buemi F; Cassarà A; Matheoud R; Sacchetti GM; Arnulfo A; Brambilla M; Carriero A
    Radiol Med; 2016 Jul; 121(7):537-45. PubMed ID: 27033474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
    Alessi A; Martinelli F; Padovano B; Serafini G; Lorusso D; Lorenzoni A; Ditto A; Lecce F; Mira M; Donfrancesco C; Raspagliesi F; Crippa F
    Tumori; 2016; 102(1):103-7. PubMed ID: 26350201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
    Lee HJ; Park JY; Lee JJ; Kim MH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2016 Mar; 140(3):409-14. PubMed ID: 26777990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
    Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
    Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
    Lee DH; Kim SH; Joo I; Hur BY; Han JK
    Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of
    Legros M; Margueritte F; Tardieu A; Deluche E; Mbou VB; Lacorre A; Ceuca A; Aubard Y; Monteil J; Sallee C; Gauthier T
    Anticancer Res; 2019 Feb; 39(2):619-625. PubMed ID: 30711937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
    Kara T; Kara PO; Gedik GK; Sari O
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Positron tomography with 18F-fluorodeoxyglucose in the preoperative evaluation of gall bladder lesions suspicious of malignancy. Diagnostic utility and clinical impact].
    Ramos-Font C; Gómez Río M; Rodríguez-Fernández A; Sánchez Sánchez R; Llamas Elvira JM
    Rev Esp Med Nucl; 2011; 30(5):267-75. PubMed ID: 21612846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
    Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
    BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.